Published 1 year ago

Pfizer CEO says there will be no generic Paxlovid for China

Summary by Ground News

Pfizer is not in talks with Chinese authorities to license a generic version of its treatment Paxlovid for use there. Chief Executive Albert Bourla said the company is in discussions about a price for the branded product. China's Healthcare Security Administration (NHSA) said that the country would not include PaxlovID in an update to its list of medicines covered by basic medical insurance schemes.

0 Articles

All

Left

Center

Right

Reuters

Pfizer CEO rules out generic COVID drug Paxlovid for China

Pfizer Inc is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said on Monday.

1 year ago·United Kingdom

Read Full Article

CNBC

Pfizer CEO says there will be no generic Paxlovid for China

Bourla said the company had shipped thousands of courses of the treatment in 2022 to China and in the past couple of weeks, had increased that to millions.

1 year ago·United States

Read Full Article

Bloomberg

Pfizer Says Partner in China Is Gearing up for Paxlovid Sales

Pfizer Inc. is working with a partner in China to make the Covid-19 drug Paxlovid available there starting in the first half of the year, Chief Executive Officer Albert Bourla said in a presentation.

1 year ago·United States

Read Full Article

Malay Mail

Pfizer CEO says there will be no generic Paxlovid for China

BEIJING, Jan 10 ― Pfizer Inc is not in talks with Chinese authorities to license a generic version of its Covid-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said yesterday. Reuters reported on Friday that China was in talks with Pfizer to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 …

1 year ago·Selangor, Malaysia

Read Full Article

FijiTimes

Pfizer working to send COVID pill Paxlovid to China

(Reuters) – Pfizer Inc is working with Chinese authorities to send its COVID-19 pill, Paxlovid, to the country that is dealing with a surge in COVID-19 cases, Chief Executive Officer Albert Bourla said in an interview with CNBC on Monday. In February last year, China approved Paxlovid to treat high-risk patients in several provinces. The drug was supposed to be largely available via hospitals. Pfizer has also reached an agreement to export Paxlo…

1 year ago·Fiji

Read Full Article

Inquirer

Pfizer working to send COVID pill Paxlovid to China – CNBC

Pfizer Inc is working with Chinese authorities to send its COVID-19 pill, Paxlovid, to the country that is dealing with a surge in COVID-19 cases, Chief Executive Officer Albert Bourla said in an

1 year ago·Manila, Philippines

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.